Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
Completed · Phase 2
Conditions studied: Stable Angina
In brief
The objective of this study is to evaluate if aggressive antiplatelet therapy would reduce ischemic events in aspirin (ASA) resistant patients after percutaneous coronary intervention (PCI).
Key facts
- Study ID
- NCT01103440
- Run by
- Icahn School of Medicine at Mount Sinai
- People needed
- 36
- Starts
- 2007-04-01
- Expected to finish
- 2009-06-01
- Last updated by the study team
- 2018-02-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age older than 18 years
- Scheduled for elective or ad-hos PCI
- Aspirin use daily for greater or equal to one week
- Aspirin resistant (ARU greater than or equal to 550 on Verify Now-ASA
You may not qualify if…
- Pre-procedural elevation of cardiac biomarkers (CK-MB greater or equal to 10.4ng/dl or Tnl greater or equal to 0.4ng/dl
- administration of any GP IIb/IIIa inhibitor, anticoagulation or lytic therapy in the previous 30 days
- Ongoing bleeding or bleeding diathesis, contraindications for anticoagulation or increased bleeding risk or history of bleeding in the last eight weeks
- Previous stroke or transient ischemic attack or any intracranial pathology in the last six months, major surgery or trauma within the previous six weeks
- Platelet count less than hundred thousand per cubic millimeter or hematocrit <33% or hemoglobin <11 g per deciliter
- Subjects who received full dose low molecular weight heparin within six hours prior to randomization
- Allergy or intolerance to any of the study drugs or the presence of any serious comorbidity with life expectancy of ≤1year
- Scheduled for saphenous vein graft intervention, chronic total occlusions or with impaired renal function (eGFR<60ml/min) or patients who were taking anticoagulants or antiplatelet agents other than aspirin and clopidogrel or nonsteroidal anti-inflammatory drugs within two weeks before the PCI procedure
Where it is running
- Mount Sinai Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.